搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
The Pharma Letter
15 小时
J&J’s Tecvayli now recommended as fourth-line myeloma option
Johnson & Johnson’s Tecvayli (teclistamab) has been recommended by NICE as a first-line treatment for myeloma in England and ...
The Pharma Letter
17 小时
End in sight for GSK's Zantac woes, with $2.2 billion deal
GSK (LSE: GSK) has settled 93% of Zantac (ranitidine) product liability cases in the USA, agreeing to pay up to $2.2 billion ...
The Pharma Letter
16 小时
EMA accepts STADA’s filing for AVT03, a proposed denosumab biosimilar
The European Medicines Agency (EMA) has accepted for review the Marketing Authorization Applications for AVT03, a proposed ...
The Pharma Letter
15 小时
Nanoscope plans to submit BLA for MCO-010
Nanoscope Therapeutics says that, following a productive FDA meeting with the US Food and Drug Administration (FDA) for its ...
The Pharma Letter
14 小时
Pfizer’s Talzenna and Xtandi combo prolongs OS in mCRPC
US pharma giant Pfizer today released positive top line results from the final prespecified overall survival (OS) analysis of ...
The Pharma Letter
10 小时
Machine learning at heart of insitro and Lilly link-up
Insitro has signed three strategic agreements with Eli Lilly aimed at advancing treatments for metabolic diseases like MASLD, ...
The Pharma Letter
17 小时
J&J taps Quantum Pharma for AI discovery platform
China's Quantum Pharmaceuticals has announced a major licensing deal between its subsidiary Ailux Biologics and Johnson & ...
The Pharma Letter
17 小时
FDA slaps another CRL on Zealand Pharma’s dasiglucagon NDA
The US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for Part 1 of the New Drug Application ...
The Pharma Letter
16 小时
Phase II InnoCare data spell competition in psoriasis
Beijing’s InnoCare Pharma has announced promising Phase II results for its TYK2 inhibitor, ICP-488, in moderate-to-severe ...
The Pharma Letter
1 天
Gritstone goes under after gruesome year
US vaccine company Gritstone bio (Nasdaq: GRTS) has filed for bankruptcy. This follows the presentation of disappointing data ...
The Pharma Letter
15 小时
Cuts for Black Diamond as runway's end nears
Black Diamond Therapeutics (Nasdaq: BDTX) is restructuring to focus on its lead drug, BDTX-1535, aimed at non-small cell lung ...
The Pharma Letter
17 小时
CMS proposes model to lower Rx drug costs for people with Medicare
Yesterday, the US Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈